SUCCESSFUL ULTRASONICALLY GUIDED PERCUTANEOUS ETHANOL INJECTION FOR SECONDARY HYPERPARATHYROIDISM

被引：17

作者：

TAKEDA, S ^{[1
]}

MICHIGISHI, T ^{[1
]}

TAKAZAKURA, E ^{[1
]}

机构：

[1] KANAZAWA UNIV,SCH MED,DEPT NUCL MED,KANAZAWA,ISHIKAWA 920,JAPAN

来源：

NEPHRON | 1992年 / 62卷 / 01期

关键词：

SECONDARY HYPERPARATHYROIDISM; UREMIA; PERCUTANEOUS ETHANOL INJECTION;

D O I：

10.1159/000187005

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Ultrasonically guided percutaneous ethanol injection to all of four enlarged parathyroid glands, which were confirmed by fine-needle aspiration biopsy, was successfully performed in a hemodialysis patient with secondary hyperparathyroidism. In addition to marked reduction of serum parathyroid hormone, the size of parathyroid glands was significantly decreased after the procedure. As an adverse effect, the patient experienced a transient self-limiting dysphonia due to right recurrent nerve palsy after the first injection. This procedure may be an effective alternative to surgical treatment or administration of high-dose 1,25(OH)2 vitamin D3 in uremic patients with sonographically verified multiple enlarged parathyroid glands.

引用

页码：100 / 103

页数：4

共 15 条

[11] MARKED SUPPRESSION OF SECONDARY HYPERPARATHYROIDISM BY INTRAVENOUS ADMINISTRATION OF 1,25-DIHYDROXYCHOLECALCIFEROL IN UREMIC PATIENTS [J].

SLATOPOLSKY, E ;

WEERTS, C ;

THIELAN, J ;

HORST, R ;

HARTER, H ;

MARTIN, KJ .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2136-2143

[12] PERCUTANEOUS ETHANOL INJECTION OF PARATHYROID TUMORS UNDER US GUIDANCE - TREATMENT FOR SECONDARY HYPERPARATHYROIDISM [J].

SOLBIATI, L ;

GIANGRANDE, A ;

DEPRA, L ;

BELLOTTI, E ;

CANTU, P ;

RAVETTO, C .

RADIOLOGY, 1985, 155 (03) :607-610

[13] PARATHYROID TUMORS-DETECTED BY FINE-NEEDLE ASPIRATION BIOPSY UNDER ULTRASONIC GUIDANCE [J].

SOLBIATI, L ;

MONTALI, G ;

CROCE, F ;

BELLOTTI, E ;

GIANGRANDE, A ;

RAVETTO, C .

RADIOLOGY, 1983, 148 (03) :793-797

[14] 1,25(OH)2 VITAMIN-D3 INHIBITS PARATHYROID CELL-PROLIFERATION IN EXPERIMENTAL UREMIA [J].

SZABO, A ;

MERKE, J ;

BEIER, E ;

MALL, G ;

RITZ, E .

KIDNEY INTERNATIONAL, 1989, 35 (04) :1049-1056

[15] THE ORAL 1,25-DIHYDROXYVITAMIN-D3 PULSE THERAPY IN HEMODIALYSIS-PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM [J].

TSUKAMOTO, Y ;

NOMURA, M ;

TAKAHASHI, Y ;

TAKAGI, Y ;

YOSHIDA, A ;

NAGAOKA, T ;

TOGASHI, K ;

KIKAWADA, R ;

MARUMO, F .

NEPHRON, 1991, 57 (01) :23-28

← 1 2 →